相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
J. Douxfils et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Robert C. Gosselin et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays
Joachim Kuhn et al.
CLINICA CHIMICA ACTA (2018)
Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation
Satoshi Ueshima et al.
PHARMACOGENETICS AND GENOMICS (2017)
Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know
Susan E. Conway et al.
PHARMACOTHERAPY (2017)
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants
Bethany T. Samuelson et al.
CHEST (2017)
ABCB1 SNP rs4148738 modulation of apixaban interindividual variability
Claudia Dimatteo et al.
THROMBOSIS RESEARCH (2016)
Laboratory Measurements of the Oral Direct Factor Xa Inhibitor Edoxaban Comparison of Prothrombin Time, Activated Partial Thromboplastin Time, and Thrombin Generation Assay
Yoshiyuki Morishima et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
Agon Mekaj et al.
Therapeutics and Clinical Risk Management (2015)
Influence of dabigatran and rivaroxaban on routine coagulation assays A nationwide Belgian survey
Marjan Van Blerk et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Laboratory Measurement of the Anticoagulant Activity of the Non-Vitamin K Oral Anticoagulants
Adam Cuker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants
E. M. H. Schmitz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Performance of coagulation tests in patients on therapeutic doses of rivaroxaban A cross-sectional pharmacodynamic study based on peak and trough plasma levels
Suzanne J. Francart et al.
THROMBOSIS AND HAEMOSTASIS (2014)
New Oral Anticoagulants: Comparative Pharmacology with Vitamin K Antagonists
Francesco Scaglione
CLINICAL PHARMACOKINETICS (2013)
Novel oral anticoagulants: clinical pharmacology, indications and practical considerations
Sebastian Harder et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban
Jonathan Douxfils et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Simultaneous quantitative determination of paracetamol and its glucuronide conjugate in human plasma and urine by liquid chromatography coupled to electrospray tandem mass spectrometry: Application to a clinical pharmacokinetic study
Qin-you Tan et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Current role of LC-MS in therapeutic drug monitoring
Franck Saint-Marcoux et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
Beyond heparin and warfarin: the new generation of anticoagulants
Jeffrey I. Weitz et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
分享论文
